ghk-cu and bpc-157 GHK‑Cu / BPC‑157 / TB‑500 GLOW Protocol Peptide Therapy in

Redness or Irritation Mild swelling or discomfort at the injection site

Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old

What they found: Mean weight loss: 2.6 kg vs 2.3 kg placebo , a difference of only 0.3 kg (1 %) Statistically non-significant Clinically unsatisfactory for the obesity indication Safety profile remained favorable Why it matters: The study stopped the development of AOD-9604 as a drug

Truth : Lipo B Injections are a safe, FDA-approved treatment when administered by a trained professional

Do not wait for routine labs Vision changes, rapid swelling, severe headaches, chest pain, shortness of breath, or allergic symptoms need medical review